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Abstract: Laurus nobilis L. (laurel, Lauraceae) and Prunus armeniaca L. (apricot, Rosaceae) are important
industrial crops and display significant biological properties, including antimicrobial activity. In this
work, essential oils (EOs) prepared from the leaves of both species from Morocco were evaluated for the
first time for possible synergistic in vitro antibacterial and antifungal effects with some conventional
antimicrobial drugs, namely fluconazole, ciprofloxacin and vancomycin. Samples were further
evaluated for chemical composition by gas chromatography–mass spectrometry (GC-MS). The main
volatile compounds detected in L. nobilis were eucalyptol (40.85%), α-terpinyl acetate (12.64%)
and methyl eugenol (8.72%), while P. armeniaca was dominated essentially by (Z)-phytol (27.18%),
pentacosane (15.11%), nonacosane (8.76%) and benzaldehyde (7.25%). Regarding antimicrobial
activity, both EOs inhibited significantly all the microorganisms tested. The EO from L. nobilis had the
highest activity, with minimal inhibitory concentrations (MICs) ranging from 1.39 to 22.2 mg/mL for
bacteria and between 2.77 and 5.55 mg/mL for yeasts. Conversely, the combination of the studied EOs
with ciprofloxacin, vancomycin and fluconazol resulted in a noteworthy decrease in their individual
MICs. In fact, of the 32 interactions tested, 23 (71.87%) demonstrated total synergism and 9 (28.12%) a
partial synergistic interaction. The EO from L. nobilis exhibited the highest synergistic effect with
all the antibiotics used, with fractional inhibitory concentration (FIC) index values in the range of
0.266 to 0.75 for bacteria, and between 0.258 and 0.266 for yeast. The synergistic interaction between
the studied EOs and standard antibiotics may constitute promising anti-infective agents useful for
treating diseases induced by antibiotic-resistant pathogens.
Keywords: antimicrobial activity; antibiotic-resistant pathogens; anti-infective agents; pharmacologically
active plant-derived natural products; synergistic interaction
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1. Introduction
In recent years there has been increasing interest in the exploitation of natural resources for
the identification of new anti-infective agents [1]. Medicinal plants, containing bioactive substances
of noteworthy therapeutic value as revealed by their traditional uses and chemical diversity, are
considered to be one of the most important sources of such compounds [2,3]. In 2008, more than
80% of the world’s population used medicinal plants and derivatives for their primary care needs [4].
In particular, volatile components such as essential oils (EOs) have attracted much attention because of
their benefits for both human health and environmental safety [5].
Nowadays one of the most pressing health problems is the appearance of many types of resistant
microbes due to the overuse of antibiotics resulting in a decline in their efficacy [6]. For example,
Staphylococcus aureus extremely emerged recently and causes potentially fatal nosocomial diseases
including necrotizing fasciitis, life-threatening pneumonia and toxinoses like toxic shock syndrome [7].
It is responsible for more than 150,000 affected patients annually in the European Union [8]. Similarly,
candidiasis caused by Candida species has become a major public health threat, with more than
250,000 affected individuals annually and a mortality rate that exceeds 70% [9]. In fact, the emergence
of multidrug-resistant microorganisms is a challenge for the treatment of infections [10], and therefore
the development of new approaches to combat these pathogens is sorely needed [11]. Among the
strategies under investigation is the combination of antibiotics with non-antibiotic adjuvants, such as
EOs, to reduce the minimum effective dose of antimicrobials needed for treatment [10,12].
Laurus nobilis L., commonly known as laurel, belongs to the Lauraceae family and is a dioecious
evergreen shrub with highly fragrant leaves. Laurel is native to the southern Mediterranean region
and is widely cultivated in many regions of the world. Laurel is mainly used in the flavoring
industry and also as a botanical biopesticide in postharvest crop protection [13]. Dried laurel leaves
are used extensively in cooking, in hair lotions because of their antidandruff activity and for the
external treatment of psoriasis [14]. The EO from laurel leaves exhibits several biological properties
such as antiviral, antimicrobial and insecticidal activity [13,15,16]. Moreover, it can be used in food
preservation [17], cancer treatment [18] and aromatherapy [19].
Prunus armeniaca L., known as apricot, is a deciduous fruit tree member of the Rosaceae family. It is
a native plant from the East, in particular China and Japan [20], and is considered to be one of the most
important temperate fruit trees, with a total production worldwide approaching 2.6 million tons [21].
Apricot has been used in traditional medicine for the treatment of several diseases, for example, its
seeds are used to treat hemorrhages, wheeze, asthma, infertility and eye inflammation [22]. Moreover,
apricot possess an antimicrobial activity specifically against skin diseases like acne vulgaris, as well as
possessing antidandruff activity [23].
In the course of our work to discover new natural anti-infective agents from natural sources, and
to boost the valorization of Moroccan plant essential oils, we report here for the first time the synergistic
antimicrobial effect of EOs from laurel and apricot leaves with conventional antimicrobial drugs,
namely fluconazole, ciprofloxacin and vancomycin. Target microorganisms included mainly those
responsible for nosocomial and mycotic diseases. The chemical profiles of the EOs were characterized
by gas chromatography–mass spectrometry (GC-MS).
2. Results and Discussion
2.1. Chemical Composition of the EOs
The preliminary analysis of the GC chromatogram of the studied EOs showed an abundance of
several volatile compounds (Table 1). The EO from apricot was characterized by 15 compounds that
collectively accounted for 98.33% of the oil’s composition. The EO contained two major compounds,
namely (Z)-phytol (27.18%) and pentacosane (15.11%). Nonacosane (8.76%), benzaldehyde (7.25%),
(E)-2-hexenal (6.54%) and heptacosane (6.50%) were also identified in appreciable levels. The EO
from laurel was characterized by 14 different compounds representing 98.57% of the total components
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of the oil. Eucalyptol (40.85%), α-terpinyl acetate (12.64%) and methyl eugenol (8.72%) were the
most abundant volatile compounds. The other main components of this EO were linalool (6.81%),
α-terpineol (5.60%), eugenol (5.14%) and sabinene (5.13%). Some of these components, for example,
(Z)-phytol, eucalyptol, α-terpinyl acetate and linalool, have a number of proven biological activities
including antimicrobial and insect-repellant properties [24,25].
Table 1. Volatile components of essential oils from apricot (P. armeniaca) and laurel (L. nobilis) leaves.
Entries in bold type are major components.
RI Name Apricot Laurel
854 (E)-2-Hexenal 6.54 -
886 Cyclofenchene - 2.03
888 p-Xylene 3.90 -
954 Ethyltoluene 2.54 -
963 Benzaldehyde 7.25 -
967.2 Sabinen - 5.13
973 α-Pinene 1.37 2.85
996 Mesitylene 2.62 -
1001 3-Carene - 1.14
1020 Eucalyptol - 40.85
1030 Limonene 2.54 -
1050 γ-Terpinene - 1.24
1086 Linalool 6.38 6.81
1164 Terpinen-4-ol - 4.07
1175 α-Terpineol - 5.60
1332 α-Terpinyl acetate - 12.64
1339 Eugenol - 5.14
1370 Methyleugenol - 8.72
1490 β-Cyclogermacrane - 1.11
1521 γ-Cadinène 1.62 -
1521 Elemicin - 1.27
1526 δ-Cadinene 0.54 -
1950 (Z)-Phytol 27.18 -
1969 Hexadecanoic acid 5.48 -
2500 Pentacosane 15.11 -
2700 Heptacosane 6.50 -
2900 Nonacosane 8.76 -
Total 98.33 98.57
Yield 1.20% 2.50%
RI: retention index measured relative to n-alkanes (C-9 to C-24) on a non-polar TG-5MS column; -: not detected.
The obtained data showed that the composition of the studied laurel EO differed quantitatively to
those previously reported in samples from other geographical regions such as Italy, Turkey, Cyprus,
Tunisia and Bulgaria. In fact, the concentration of eucalyptol in our samples was lower than the
values recorded in Tunisia (56%) [26], Cyprus (58.59%) [27] and Bulgaria (41%) [16]. However, it was
higher compared with those found in other studies, namely Algeria (34.62%) [15]. As previously
reported, the variability in the chemical composition of the EO can be greatly affected particularly by
the geographical location, the climate, the harvest period and genetic factors [6,28].
2.2. Antimicrobial and Synergistic Effect of EO
Results of the evaluation of the antimicrobial activity using the disc diffusion method are presented
in Tables 2 and 3. Both EOs exhibited notable potency, with inhibition zones (IZs) ranging from 9.00
mm in the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa (laurel) to 28 mm in
the yeast Candida glabrata (apricot). The minimum inhibitory concentration (MIC) data obtained by
the microdilution method revealed significant activity especially against the Candida strains, with
values ranging from 2.77 in C. parapsilosis to 5.55 mg/mL in the other strains (for laurel) and from
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5.84 in C. glabrata, C. krusei and C. parapsilosis to 11.7 mg/mL in C. albicans (for apricot). The results
showed also that apricot exhibited a moderate efficiency against the Gram-positive bacteria especially
towards S. aureus and Bacillus subtilis, with MIC values of 5.55 and 1.39 mg/mL, respectively. The laurel
EO demonstrated the highest activity against all tested Gram-negative bacteria (MIC: 11.7 mg/mL).
Concerning the minimal fungicidal concentration (MFC), both EOs exhibited values close to those
obtained for MIC with small variations. For example, laurel EO has an effect against B. subtilis and
C. parapsilosis with MFCs of 2.77 and 5.55 mg/mL, respectively. Apricot EO acts against E. coli and
Klebsiella pneumoniae with an MFC of 23.4 mg/mL and C. parapsilosis with 11.70 mg/mL. Our findings
are in agreement with those reported by several authors for the same species [16,29].
Table 2. Inhibition zone diameters, MIC and MBC of essential oils from apricot (P. armeniaca) and
laurel (L. nobilis) leaves, and antibiotics, against bacteria using the disc diffusion and micro-well
dilution assays.
Microorganisms
Apricot Laurel Ciprofloxacin Vancomycin
IZ MIC MBC IZ MIC MBC IZ MIC IZ MIC
Gram-positive bacteria
M. luteus 12.0 ± 0.10 23.4 23.4 10.0 ± 0.33 22.2 22.20 26.0 ± 0.75 0.01 28.0 ± 0.20 0.001
S. aureus 14.0 ± 0.20 23.4 23.4 10.0 ± 0.31 5.55 5.55 27.0 ± 0.40 0.03 27.0 ± 0.32 0.001
B. subtilis 14.0 ± 0.05 23.4 23.4 14.0 ± 0.20 1.39 2.77 35.0 ± 1.20 0.01 24.0 ± 0.40 0.125
Gram-negative bacteria
E. coli 18.0 ± 0.25 11.7 23.4 9.00 ± 0.45 >22.5 >22.5 12.0 ± 0.80 0.06 12.0 ± 0.13 0.5
P. aeruginosa 22.0 ± 0.12 11.7 11.7 9.00 ± 0.54 22.2 22.2 9.00 ± 0.20 1 11.0 ± 0.24 0.5
K. pneumoniae 13.0 ± 0.40 11.7 23.4 9.00 ± 0.60 >22.5 >22.5 8.00 ± 0.82 0.25 11.0 ± 0.19 0.5
IZ: inhibition zone (mm); MIC: minimum inhibitory concentration (mg/mL); MBC: minimum bactericidal
concentration (mg/mL).
Table 3. Inhibition zone diameters, MIC and MFC of essential oils from apricot (P. armeniaca) and laurel
(L. nobilis) leaves against yeasts using the disc diffusion and micro-well dilution assays.
Microorganisms
Apricot Laurel Fluconazol
IZ MIC MFC IZ MIC MFC IZ MIC
Yeasts
C. albicans 12.00 ± 0.70 11.70 11.70 10.00 ± 0.21 5.55 5.55 20.00 ± 0.50 1
C. glabrata 28.00 ± 0.90 5.85 5.85 13.00 ± 0.12 5.55 5.55 13.00 ± 0.00 1
C. krusei 25.00 ± 0.31 5.85 5.85 15.00 ± 0.7 5.55 5.55 24.00 ± 0.80 1
C. parapsilosis 26.00 ± 0.81 5.85 11.70 9.00 ± 0.88 2.77 5.55 28.20 ± 0.43 1
IZ: inhibition zone (mm); MIC: minimum inhibitory concentration (mg/mL); MFC: minimum fungicidal concentration
(mg/mL).
The results of synergistic interaction of both EOs with antibiotics are summarized in Tables 4
and 5. On the basis of fractional inhibitor concentration index (FICI) values, of 32 interactions tested,
23 (71.87%) represented total synergism and 9 (28.12%) a partial synergistic interaction. The interaction
of both EOs with fluconazol resulted in a total synergistic effect against all tested yeasts (FICI from
0.258 to 0.375). For bacterial strains, the interaction of the EO of laurel with the two antibiotics
allowed for a total synergism for all bacteria (FICI from 0.266 to 0.5) except for P. aeruginosa (FICI: 0.75).
The interaction of P. armeniaca EO with vancomycin resulted in a partial synergistic effect (FICI: 0.75)
and with ciprofloxacin presented a total synergism (FICI from 0.258 to 0.5) except for B. subtilis and M.
luteus (FICI: 0.75).
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Table 4. Synergistic interaction between laurel (L. nobilis) and apricot (P. armeniaca) essential oils and ciprofloxacin against resistant bacteria.
Combination
M. luteus S. aureus B. subtilis E. coli P. aeruginosa K. pneumoniae
FIC FICI Gain FIC FICI Gain FIC FICI Gain FIC FICI Gain FIC FICI Gain FIC FICI Gain
P. armeniaca EO 0.25 - - 0.25 - - 0.25 - - 0.25 - - 0.25 - - 0.25 - -
Ciprofloxacin 0.5 0.75 b 2 0.25 0.5 a 4 0.5 0.75 b 2 0.062 0.312 a 16 0.008 0.258 a 128 0.125 0.375 a 8
Vancomycin 0.5 0.75 b 2 0.5 0.75 b 2 0.5 0.75 b 2 0.25 0.75 b 4 0.5 0.75 b 2 0.5 0.75 b 2
L. nobilis EO 0.25 - - 0.25 - - 0.25 - - 0.25 - - 0.25 - - 0.25 - -
Ciprofloxacin 0.25 0.5 a 4 0.062 0.312 a 16 0.25 0.5 a 4 0.125 0.375 a 8 0.016 0.266 a 64 0.063 0.313 a 16
Vancomycin 0.247 0.497 a 4 0.247 0.497 a 4 0.125 0.375 a 8 0.25 0.5 a 4 0.5 0.75 b 2 0.125 0.375 a 8
FIC: fractional inhibitory concentration; FICI: fractional inhibitor concentration index; FIC of oil = (MIC of EO in combination with antibiotic)/(MIC of EO alone); FIC of antibiotic = (MIC of
antibiotic in combination with EO)/(MIC of antibiotic alone); FIC index = FIC of EO + FIC of antibiotic. a Total synergism; b Partial synergism.
Table 5. Synergistic interaction between laurel (L. nobilis) and apricot (P. armeniaca) essential oils and fluconazol against clinical pathogenic yeasts.
Combination
C. albicans C. glabrata C. krusei C. parapsilosis
FIC FICI Gain FIC FICI Gain FIC FICI Gain FIC FICI Gain
P. armeniaca EO 0.25 - - 0.25 - - 0.25 - - 0.25 - -
Fluconazole 0.031 0.281 a 32 0.016 0.266 a 64 0.125 0.375 a 8 0.063 0.313 a 16
L. nobilis EO 0.25 - - 0.25 - - 0.25 - - 0.25 - -
Fluconazole 0.008 0.258 a 128 0.008 0.258 a 128 0.16 0.266 a 64 0.16 0.266 a 64
FIC: fractional inhibitory concentration; FICI: fractional inhibitor concentration index; FIC of oil = (MIC of EO in combination with antibiotic)/(MIC of EO alone); FIC of antibiotic = (MIC of
antibiotic in combination with EO)/(MIC of antibiotic alone); FIC index = FIC of EO + FIC of antibiotic. a Total synergism.
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The gain expressed by the MIC of antibiotics in the presence of EOs at a sub-inhibitory concentration
(MIC/4) is summarized in Tables 4 and 5. Both EOs strongly decreased the antibiotic MICs by 2- to
128-fold against all tested strains. The highly reduced MICs (128-fold) were noted for the combination
of the EO from apricot with ciprofloxacin against P. aeruginosa, and of laurel with fluconazol against
C. albicans and C. glabrata. The results obtained indicated that the mixture of EOs of both plants
with the antimicrobial agents improved the effectiveness of the latter. This improvement can be
explained by the presence of high levels of eucalyptol in the EO from laurel, and one major compound
in apricot (Z-phytol), based on the performed approximate quantification. Eucalyptol is a major
component of the EO from several species, in particular the Eucalyptus genus [30], and is a recognized
antimicrobial agent [31,32]. This compound acts on the plasma membranes and is used for its
antitussive effects and in aromatherapy as a skin stimulant [33]. It is also used to treat sinusitis,
rheumatism and bronchitis [34]. Phytol exhibits broad-spectrum antimicrobial effects against infective
endocarditis bacteria and Enterococcus faecalis [31]. Moreover, phytol acts against protein and enzyme
inactivation of the important mechanisms of microorganisms [35]. This compound also exhibits several
other biological activities such as anti-inflammatory, cytotoxic, metabolic and immune-modulating
effects [36,37]. For example, it may prevent types of events such as DNA damage due to its hydroxyl
radical scavenging capacity [31]. The synergistic effect demonstrated especially in the case of laurel
EO with ciprofloxacin might be due to the correlation between the chemical composition profile and
the antimicrobial activity, suggesting that the potential of tested EO could be associated with the
highest concentration of eucalyptol known to be an antimicrobial agent that has been previously
reported. Plant metabolites that produce a synergistic effect have some generally accepted mechanisms
of antimicrobial action including the use of membranotropic agents to enhance antimicrobial diffusion,
sequential or dose-dependent effects on common biochemical pathways, and inhibition of protective
enzymes [38,39].
3. Materials and Methods
3.1. Plant Material
Leaves of L. nobilis were harvested in February 2019 from Ait Ourir (31◦27’N/07◦32’W), while
P. armeniaca leaves were collected in October 2018 from Tassaltante (31◦32’N/7◦57’W), both in the
Marrakech region. The voucher specimens (LANO-41 for L. nobilis and PUAR-42 for P. armeniaca) were
maintained at the Laboratory of Biology and Biotechnology of Microorganisms, Faculty of Sciences
Semlalia, Cadi Ayyad University, Marrakech, Morocco. The collected samples were air-dried at room
temperature (approximately 25 ◦C) in the shade for 1 week.
3.2. Extraction of EOs
The EOs were extracted from the dried leaves by steam distillation for 4 h using a Clevenger-type
apparatus according to Price and Price [40], and yielded (v/w) 2.5% for L. nobilis and 1.2% from
P. armeniaca, based on the dry weight (DW).
3.3. Chemical Profiling of the EOs by GC-MS
GC-MS coupled to TG-5MS column (30 m length; 0.25 mm i.d.; 0.25 µm film thickness) and
coupled to mass selective detector “ISQ Single Quadrupole Mass spectrometer” (70 eV) was used to
characterize both Eos, and the conditions for the analysis were as described previously [28]. Briefly, the
injector temperature was 260 ◦C, helium was the carrier gas, and the temperature program was 1 min
at 100 ◦C ramped from 100 to 260 ◦C at 4 ◦C/min and 10 min at 246 ◦C. Identification of the individual
components was assigned by comparing their mass spectra and retention indexes with reference library
data [41]. For semi-quantification purposes, the normalized peak area of each compound was used
without any correction factors to establish the components’ relative concentrations.
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3.4. Antimicrobial Evaluation and Determination of Minimum Inhibitory Concentration (MIC) and Minimum
Microbicidal Concentration (MMC)
For the evaluation of the antibacterial activity of the EOs, six pathogenic strains were used, namely
Staphylococcus aureus, Micrococcus luteus, Bacillus subtilis, Escherichia coli, Pseudomonas aeruginosa and
Klebsiella pneumoniae. In addition, antifungal activity was evaluated using four pathogenic yeasts
belonging to the Candida genus, namely C. albicans, C. glabrata, C. krusei and C. parapsilosis (Table 6).
All strains were conserved at −80 ◦C and were grown on Muller Hinton medium for bacteria (24 h)
and Sabouraud medium for yeasts (48 h) prior to the assays.
Table 6. Bacterial and yeast strains used in this study.
Bacteria Access number Reference
Staphylococcus aureus CCMM B3 [42]
Micrococcus luteus ATCC 10240 [42]
Bacillus subtilis ATCC 9524 [42]
Escherichia coli ATCC 8739 [42]
Pseudomonas aeruginosa ATCC 10240 [42]
Klebsiella pneumoniae Clinically isolated [42]
Yeasts
Candida albicans CCMM-L4 [43]
Candida glabrata CCMM-L7 [43]
Candida krusei CCMM-L10 [43]
Candida parapsilosis CCMM-L18 [43]
As described by Helal et al. [44] the disc-diffusion method was used to evaluate antimicrobial
activity. Petri dishes containing Sabouraud and Muller Hinton (MH) agar were seeded with a
cell suspension of yeasts (105 CFU/mL) and bacteria (108 CFU/mL), respectively. Sterile paper
discs (6 mm) were individually loaded with 10 µL of each EO and placed on the surface of the
previously inoculated media. The plates were incubated at the optimal temperature of each tested
microorganism. The antimicrobial potential was evaluated by measuring the inhibition zones (in mm).
The microdilution method in 96-well plates was used to determine the MIC which corresponded to the
lowest concentration of EO able to inhibit bacterial cell growth [45]. In each microwell, 100 µL of EO
dilution (from 93 to 0.36 mg/mL for apricot and 90 to 0.35 mg/mL for laurel) was added to the same
volume of yeast inoculum (1–2 103 cells/mL) and bacteria (106 CFU/mL). The last three wells of each
row that showed no microbial growth after plate incubation were used to determine the minimum
microbicidal concentration (bactericidal and fungicidal). For this, an inoculum from each well was
inoculated on Muller Hinton agar plates for bacteria and Sabouraud agar plates for yeasts. The plates
were incubated at 37 ◦C (24 h) and 30 ◦C (48 h) for bacteria and yeasts, respectively. The MBC and MFC
were noted for the concentration where no colonies developed [46]. Fluconazole was used as a positive
control for fungi, while ciprofloxacin and vancomycin were used as positive controls for bacteria.
3.5. Evaluation of Synergistic Effect of the EOs with Conventional Antibiotics
Three standard antimicrobial agents, namely fluconazol, vancomycin and ciprofloxacin,
in combination with each EO were used to evaluate their synergistic effect by the checkerboard
assay method described by Nafis et al. [29]. This synergy has been studied by determining the new
MIC of antibiotics in the presence of EOs at a lower concentration (MIC/4), based on preliminary
tests [47]. Briefly, an aliquot (50 µL) of each EO was added separately to microwells containing 50 µL
of different antimicrobial concentrations, and inoculated with 100 µL of cell suspension. As reported
by Didry et al. [48], the combined effects were calculated in terms of fractional inhibitor concentration
index (FICI), which is most frequently used to define or describe drug interactions and which represents
the sum of the FICs of each drug tested. Moreover, the gain was calculated based on the MIC of
antibiotic alone and in combination with the EOs.
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The FIC index was determined using the following formula: FICI = FIC of EO + FIC of antimicrobial,
with FIC of EO = (MIC of EO in combination with antibiotic)/(MIC of EO alone), and FIC of antimicrobial
= (MIC of antimicrobial in combination with EO)/(MIC of antimicrobial alone).
The results were interpreted as total synergism when FICI ≤ 0.5, partial synergism when 0.5 <
FICI ≤ 0.75, no effect when 0.75 < FICI ≤ 2 or antagonism when FICI > 2.
The MIC gain of the antimicrobials was calculated according to the following formula: MIC gain
= MIC of antimicrobial alone/MIC of antimicrobial in combination.
4. Conclusions
This work reports the chemical composition and the in vitro antimicrobial activity of EOs from
leaves of Moroccan laurel (L. nobilis) and apricot (P. armeniaca), when applied alone or in combination
with conventional antimicrobials, namely fluconazole, ciprofloxacin and vancomycin. The main
components of laurel EO were eucalyptol, α-terpinyl acetate and methyl eugenol. The oil from apricot
was rich in Z-phytol, pentacosane and nonacosane. According to the antimicrobial results, both species
displayed notable activity towards all tested strains, and laurel exhibited the highest antimicrobial
activity. Additionally, both EOs have a high potential to reduce the individual MICs of all the standard
antibiotics tested, especially the EO obtained from laurel. Taken together, our results suggest that EOs
from both species should be further investigated as a promising source of natural compounds that can
be used in combination with standard antibiotics to combat multidrug-resistant strains.
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